UOC
SLN

UBS O'Connor’s Silence Therapeutics SLN Stock Holding History

UBS O'Connor’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-62,639
Closed -$177K – 447
2025
Q1 		$177K Sell
62,639
-66,351
-51% -$324K ﹤0.01% 252
2024
Q4 		$887K Buy
128,990
+43,289
+51% +$559K 0.02% 241
2024
Q3 		$1.56M Buy
85,701
+8,861
+12% +$165K 0.04% 213
2024
Q2 		$1.46M Buy
76,840
+4,617
+6% +$98.2K 0.04% 238
2024
Q1 		$1.56M Sell
72,223
-20,975
-23% -$456K 0.04% 225
2023
Q4 		$1.62M Sell
93,198
-5,128
-5% -$57.6K 0.05% 208
2023
Q3 		$967K Hold
98,326
– – 0.02% 335
2023
Q2 		$541K Buy
98,326
+2,943
+3% +$17.7K 0.01% 440
2023
Q1 		$591K Buy
+95,383
New +$1.12M 0.01% 452
2022
Q4 		– Sell
-79,636
Closed -$786K – 279
2022
Q3 		$786K Buy
79,636
+50,820
+176% +$535K 0.01% 767
2022
Q2 		$341K Buy
+28,816
New +$350K ﹤0.01% 830

Other funds holding SLN

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return